Oxford International’s 7th annual Drug Discovery and Technology Leaders Summit 13th-15th November 2006 Orlando, USA
Last Updated on Wednesday, 17 May 2006 06:18 Written by admin Wednesday, 17 May 2006 06:18
Oxford International are proud to announce the 7th Annual Drug Discovery and Technology Leaders Summit being held on 13th – 15th November 2006 at the JW Marriott, Grande Lakes, Orlando, USA.
The summit programme will consider how to successfully manage R&D productivity with the aim of shortening time to market through taking a more targeted approach to discovery processes and technologies.
Over three days, the summit will attract over 100 senior-level decision makers working in drug discovery from the USA’s leading pharmaceutical and biotech companies. The Summit provides attendees with the unprecedented opportunity to address key industry concerns and network with their peers in a professional and relaxed environment.
The conference programme consists of over 15 case study presentations, delivered by senior-level industry speakers from companies such as Boehringer Ingelheim, Pfizer, Abbott Laboratories and Schering-Plough.
Key topics include:
·        TRANSLATIONAL APPROACH TO DISCOVERY:
Developing and maintaining a translational strategy – bridging the gap and speeding time to market
·        PREDICTIVE DISCOVERY TECHNOLOGIES:
Achieving the successful integration of predictive technologies
Biomarkers: determining and measuring the business case for developing and integrating biomarkers
·        OPTIMISING LEAD GENERATION AND VALIDATION:
Effective utilisation of genomics, proteomics, metabolomics, and HTS/HCS
·        DEVELOPING NEW APPROACHES TO DISCOVERY:
Employing structural biology and medicinal chemistry methodologies
·        INTEGRATING CHEM- AND BIO-INFORMATICS:
Achieving interoperability and integrating informatics, chem- and bio-informatics within discovery
·        STRATEGY:
Consolidating the discovery and development process: cutting costs, increasing efficiencies and maximising productivity
·        PORTFOLIO MANAGEMENT:
Strategically managing the discovery portfolio: the business case for emerging technologies and alliances and partnerships
The summit presents an ideal opportunity for you to raise your profile, become fully up-to-date on the most recent developments in the industry, meet peers, catch up on the latest research and gain information on new services.
For more information on delegate registration or sponsorship opportunities, please visit the event website at: www.usdrugdiscoverysummit.com or contact Joanne Taylor on +44 (0) 870 890 3303 or by emailing: joanne.taylor@oxfordint.co.uk and quote DDSUS06BS1.
Main Menu
- Home
- About Bioscreening.net
- Glossary
- Biotechnology Glossary A-I
- Biotechnology Glossary J-Q
- Biotechnology Glossary R-Z
- Bird Flu
- Cheminformatic Glossary
- Endotoxins
- Fullerenes
- Genipin
- Gossypol (Gossipol)
- Grants, Venture Capital, and Government Funding
- High-throughput screening
- Lipinski Rule-of-Five
- Mumie
- Natural Medicine
- Rule-of-Three (Ro3)
- Targeted Libraries
- Web Directory